The use of race and ethnicity in medicine: Lessons from the African-American Heart Failure Trial

Journal of Law, Medicine and Ethics

Volumn 34, Issue 3, 2006, Pages 552-554

  Cohn, Jay N ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRALAZINE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE HYDRALAZINE COMBINATION; ISOSORBIDE-HYDRALAZINE COMBINATION; VASODILATOR AGENT;

AFRICAN AMERICAN; CIVIL RIGHTS; CLASSIFICATION; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; ETHICS; ETHNOLOGY; EVIDENCE BASED MEDICINE; GENETICS; HEART FAILURE; HUMAN; MEDICAL RESEARCH; PATIENT SELECTION; PHARMACOGENETICS; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL PSYCHOLOGY; UNITED STATES;

AFRICAN AMERICANS; BIOMEDICAL RESEARCH; CIVIL RIGHTS; DRUG COMBINATIONS; ETHICAL ANALYSIS; EVIDENCE-BASED MEDICINE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; HYDRALAZINE; ISOSORBIDE DINITRATE; PATIENT SELECTION; PHARMACOGENETICS; PREJUDICE; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES; VASODILATOR AGENTS;

EID: 33749424164     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2006.00068.x     Document Type: Conference Paper

References (14)

1. See the conference video at 〈www.lifesci.consortinm.umn.edu/conferences/conferences.php〉 (last visited April 19, 2006);
2. T. Duster, "Lessons from History: Why Race and Ethnicity Have Played a Major Role in Biomedical Research." Journal of Law, Medicine & Ethics 34, no. 3 (2006): 487-496.
3. See conference video, supra note 1;
4. M. K. Cho, "Racial and Ethnic Categories in Biomedical Research: There Is No Baby in the Bathwater," Journal of Law, Medicine & Ethics 34, no. 3 (2006): 497-499.
5. J. N. Cohn, S. Julius, J. Neutel, M. Weber, P. Turlapaty, Y. Shen, V. Dong, A. Batchelor, W. Guo, and H. Lagast, "Clinical Experience with Perindopril in African-American Hypertensive Patients: A Large United States Community Trial," American Journal of Hypertension 17 (2004): 134-38.
6. See conference video, supra, note 1;
7. D. E. Roberts, "Legal Constraints on the Use of Race in Biomedical Research: Toward a Social Justice Framework," Journal of Law, Medicine & Ethics 34, no. 3 (2006): 526-534.
8. J. N. Cohn, "Lumpers Versus Splitters," Journal of Cardiac Failure 6 (2000): 75-76.
9. A. L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino, Jr., K. Ferdinand, M. Taylor, K. Adams, M. Sabolinski, M. Worcel, and J. N. Cohn for the African-American Heart Failure Trial Investigators, "Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure," New England Journal of Medicine 351 (2004): 2049-57.
10. C. W. Yancy, "Heart Failure in African-Americans : A Cardiovascular Enigma," Journal of Cardiac Failure 6 (2000): 183-86.
11. P. Carson, S. Ziesche, G. Johnson, and J. N. Cohn for the Vasodilator-Heart Failure Trial Study Group, "Racial Differences in Response to Therapy for Heart Failure: Analysis of the Vasodilator-Heart Failure "Trials," Journal of Cardiac Failure 5 (1999): 178-87.
12. See conference video, supra note 1;
13. M. G. Bloche, "Race, Money & Medicines," Journal of Law, Medicine & Ethics 34, no. 3 (2006): 555-558.
14. J. N. Cohn, "Evidence-Based Medicine: What Is the Evidence?" Journal of Cardiac Failure 2 (1996): 159-61.